ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,765
0,00%
Bitcoin
64 095,47
0,32%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Verrica Parmaceuticals Inc (VRCA)

  7. Verrica Parmaceuticals Inc (VRCA) Actualités

VRCA Verrica Parmaceuticals Inc

7,26
0,50 (7,40%)
04 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Verrica Parmaceuticals Inc VRCA NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,50 7,40% 7,26 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
6,84 6,7095 7,31 7,26 6,76
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
29/2/202414:05EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
29/2/202413:45EDGAR2Form 8-K - Current report
08/1/202414:01EDGAR2Form 8-K - Current report
16/11/202322:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/11/202322:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/11/202322:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/11/202322:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/11/202322:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/11/202316:28EDGAR2Form 144/A - Report of proposed sale of securities: [Amend]
15/11/202322:54EDGAR2Form 144 - Report of proposed sale of securities
15/11/202322:42EDGAR2Form 144 - Report of proposed sale of securities
15/11/202322:21EDGAR2Form 144 - Report of proposed sale of securities
15/11/202322:16EDGAR2Form 144 - Report of proposed sale of securities
15/11/202322:07EDGAR2Form 144 - Report of proposed sale of securities
09/11/202313:54EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202313:41EDGAR2Form 8-K - Current report
28/8/202322:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/8/202322:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/8/202322:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/8/202322:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/8/202313:52EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202313:40EDGAR2Form 8-K - Current report
27/7/202322:15EDGAR2Form 8-K - Current report
27/7/202319:16EDGAR2Form 144 - Report of proposed sale of securities
27/7/202319:09EDGAR2Form 144 - Report of proposed sale of securities
27/7/202319:01EDGAR2Form 144 - Report of proposed sale of securities
27/7/202318:53EDGAR2Form 144 - Report of proposed sale of securities
26/7/202322:21EDGAR2Form 8-K - Current report
25/7/202322:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/7/202322:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/7/202322:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/7/202322:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/7/202313:31EDGAR2Form 8-K - Current report
22/7/202301:28DJNStocks to Watch: AMC Entertainment, Becton Dickinson and..
21/7/202323:05DJNVerrica Pharmaceuticals' Molluscum Contagiosum Topical..

Dernières Valeurs Consultées

NASDAQ
VRCA
Verrica Parmaceuticals
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés